A detailed history of Rise Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 477 shares of EW stock, worth $35,956. This represents 0.02% of its overall portfolio holdings.

Number of Shares
477
Previous 477 -0.0%
Holding current value
$35,956
Previous $44,000 29.55%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$72.54 - $95.56 $19,223 - $25,323
265 Added 125.0%
477 $45,000
Q3 2023

Oct 10, 2023

BUY
$69.28 - $93.38 $6,373 - $8,590
92 Added 76.67%
212 $14,000
Q3 2022

Oct 11, 2022

BUY
$82.37 - $107.29 $9,884 - $12,874
120 New
120 $10,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.